Pharmacy benefit manager CVS Caremark decided to replace Zepbound with Wegovy for use in weight loss starting July 1, despite Zepbound users having more weight loss success.

Wegovy will now be the GLP-1 weight loss drug of choice under plans that are managed by CVS Caremark. If they stay on Zepbound for their GLP-1 weight loss treatment, they will have to pay full ...

CVS Caremark said in May that the move will save its employer clients 10 to 15% when compared to the previous year, the newspaper reported. Some employers won’t pay for either treatment because ...

A family-run homecare company which is marking its 10th anniversary in 2025 has further reason to celebrate after once again being named as one of the top 20 recommended providers in the Yorkshire ...

Starting Tuesday, CVS Caremark – a major pharmacy benefit manager that serves as a middleman for health insurers, large employers and other payers to manage their prescription drug plans ...

People who have had success with Zepbound may be able to file for an exception after the insurance coverage changes, but CVS Caremark has limited options to proactively plan for the change ...